Submission of Regulatory Application to MCA

Cookie Notification

We use cookies to collect information about how our website is used and to improve the visitor experience. You can change your browser's cookie settings at any time. Please review our privacy policy for more information. OK

Mar 04, 2003

GW announces that the regulatory dossier for the Company’s first cannabis-based prescription medicine has been submitted to the UK Medicines Control Agency as planned.

- Ends -

GW Pharmaceuticals pl: (12/12/05) + 44 20 7067 0700

Dr Geoffrey Guy, Chairman

Justin Gover, Managing Director

Weber Shandwick SquareMile: + 44 20 7067 0700

Kevin Smith/Graham Herring

Recent News